NO20010119D0 - Preparater omfattende GABA-analoger og kaffein - Google Patents

Preparater omfattende GABA-analoger og kaffein

Info

Publication number
NO20010119D0
NO20010119D0 NO20010119A NO20010119A NO20010119D0 NO 20010119 D0 NO20010119 D0 NO 20010119D0 NO 20010119 A NO20010119 A NO 20010119A NO 20010119 A NO20010119 A NO 20010119A NO 20010119 D0 NO20010119 D0 NO 20010119D0
Authority
NO
Norway
Prior art keywords
caffeine
preparations
gaba analogues
gaba
analogues
Prior art date
Application number
NO20010119A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010119L (no
Inventor
Leslie Magnus-Miller
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20010119L publication Critical patent/NO20010119L/no
Publication of NO20010119D0 publication Critical patent/NO20010119D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010119A 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein NO20010119D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (2)

Publication Number Publication Date
NO20010119L NO20010119L (no) 2001-01-08
NO20010119D0 true NO20010119D0 (no) 2001-01-08

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010119A NO20010119D0 (no) 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein

Country Status (13)

Country Link
US (1) US6326374B1 (enExample)
EP (1) EP1094817A1 (enExample)
JP (1) JP2002520286A (enExample)
KR (1) KR20010071777A (enExample)
AU (1) AU772156B2 (enExample)
BR (1) BR9911917A (enExample)
CA (1) CA2332915C (enExample)
ID (1) ID28277A (enExample)
NO (1) NO20010119D0 (enExample)
NZ (1) NZ508490A (enExample)
PL (1) PL345340A1 (enExample)
WO (1) WO2000002562A1 (enExample)
ZA (1) ZA200007168B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001876A (en) 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
WO2000061188A1 (en) * 1999-04-09 2000-10-19 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ATE317280T1 (de) 2001-09-03 2006-02-15 Newron Pharm Spa Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung
RU2335342C2 (ru) * 2004-03-12 2008-10-10 Уорнер-Ламберт Компани Ллс C1-симметричные бисфосфиновые лиганды и их применение в асимметрическом синтезе прегабалина
JP2007530657A (ja) * 2004-04-01 2007-11-01 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Pキラル性ホスホランの調製および不斉合成でのその使用
EA200800909A1 (ru) 2004-06-21 2008-08-29 УОРНЕР-ЛАМБЕРТ КОМПАНИ ЭлЭлСи Получение прегабалина и родственных соединений
SI1809271T1 (sl) * 2004-09-10 2010-10-29 Newron Pharm Spa Uporaba (R)-(halobenziloksi) benzilamino propanamidov kot selektivnih modulatorjev natrijevih in/ali kalcijevih kanalov
EP1963280B1 (en) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
JP5592790B2 (ja) 2007-08-06 2014-09-17 トリニティ ラボラトリーズ インコーポレイテッド 慢性疼痛およびニューロパシーに関連する疼痛を治療する医薬組成物
SG157299A1 (en) * 2008-05-09 2009-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) * 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
CA2170485C (en) * 1993-09-07 2000-11-07 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
US5443838A (en) 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
PL185991B1 (pl) * 1996-03-14 2003-09-30 Warner Lambert Co Nowe podstawione cykliczne aminokwasy i kompozycja farmaceutyczna
DE69733081T2 (de) * 1996-08-23 2006-05-11 Endo Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
AU733896B2 (en) * 1996-10-23 2001-05-31 Warner-Lambert Company Substituted gamma aminobutyric acids as pharmaceutical agents
WO1999012537A1 (en) * 1997-09-08 1999-03-18 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
BR9911917A (pt) 2001-03-27
PL345340A1 (en) 2001-12-17
NZ508490A (en) 2003-08-29
CA2332915C (en) 2006-10-24
CA2332915A1 (en) 2000-01-20
US6326374B1 (en) 2001-12-04
NO20010119L (no) 2001-01-08
KR20010071777A (ko) 2001-07-31
JP2002520286A (ja) 2002-07-09
ZA200007168B (en) 2002-03-04
AU4691099A (en) 2000-02-01
WO2000002562A1 (en) 2000-01-20
ID28277A (id) 2001-05-10
EP1094817A1 (en) 2001-05-02
AU772156B2 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
IS5525A (is) Innúðabúnaður og aðferð
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
IS5744A (is) Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20000700D0 (no) Interleukin-18-proteiner samt fremstilling og anvendelse derav
NO20032753D0 (no) Forbindelse og anvendelse derav
NO972911D0 (no) Stabiliserte ribozym-analoger
NO20000943D0 (no) 5-alkyl-2-arylaminofenyleddiksyrer og derivater
NO986208D0 (no) Vandige peptidformuleringer
NO991150D0 (no) Pyrazolopyrimidiner og pyrazolotriaziner
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
NO20010119D0 (no) Preparater omfattende GABA-analoger og kaffein
DE69823830D1 (de) Dermatologische zubereitungen
NO20000057L (no) Kjernerør
NO995683D0 (no) Vitamin D analoger og deres neuronale effekter
NO993731L (no) Pyrrolopyrazolopyrimidin-forbindelse og medisin omfattende denne
DE59707298D1 (de) Desodorierende zubereitungen
EE04701B1 (et) Kihisevad preparaadid
DK0826679T3 (da) Naphthylforbindelser og -præparater
DK0929577T3 (da) Stabiliserede proteinholdige protease-inhibitorer og varianter deraf
DE69806784D1 (de) Spieldose
FI974044A0 (fi) Spis
NO983556L (no) Formulering og anvendelse
FR2802775B1 (fr) Preparations glacees et aerees
DE69926005D1 (de) Carbamat- und carbazatketolidantibiotika